Your Messages Inbox
Your Article Summary
See Latest ArticlesCytokinetics to Hold a Conference Call Tuesday, May 2009 to Discuss its Collaboration and Option Agreement with Amgen
Cytokinetics, 05/27/09
Cytokinetics, Incorporated is scheduled to hold a conference call on Tuesday, May 2009 to discuss its Collaboration and Option Agreement with Amgen relating to its cardiac contractility program that includes CK-1827452, a novel cardiac myosin activator, as a potential treatment for heart failure.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09
Article Search
Sponsor